Lexaria reports promising drug delivery study results
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX), a leader in drug delivery platforms with a market capitalization of $31.77 million, has announced significant advancements in its DehydraTECH ...
Le Lézard6h
Lexaria Releases Annual Letter from the CEO
KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. , (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide this annual letter from ...
BBC Good Food on MSN11h
Weight loss drugs – are they right for you?
Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...
How to Play NVO Stock After New Drug's Success in Obesity Study
The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...
Creative Counting Can’t Fix The Inflation Reduction Act's Flaws
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.